June 4, 2020

Winship Invest$ names pilot grant recipients

Photo of Winship Invest$ names pilot grant recipients

Seven investigators will receive nearly $200,000 in funding for prostate cancer research pilot grants through Winship Invest$.

Winship Invest$ has announced that seven investigators will receive nearly $200,000 in funding for prostate cancer research pilot grants thanks to contributions from the Dunwoody Country Club Champions Golf Association and the club's John H. Kauffman Prostate Cancer Fundraiser. The Prostate Cancer Research Pilot Grant program is designed to enhance the development of robust prostate cancer research at Winship and fund innovative proposals that address basic or translational research, investigator-initiated clinical trials, health disparities, imaging, survivorship or quality of life.

This cycle's Winship Invest$ Prostate Cancer Research Pilot Grant recipients are:

  • Lara Harik, MD
    Assistant Professor, Department of Pathology & Laboratory Medicine
    Emory University School of Medicine
    Molecular Genetic Profiling of African American Patients with Prostatic Adenocarcinoma, Metastatic to the Lymph Nodes
  • Brian Olson, PhD
    Instructor, Department of Hematology and Medical Oncology
    Emory University School of Medicine
    Utilizing BET inhibition to induce DNA damage in Rb-deficient prostate cancer to enhance the efficacy of immunotherapy
  • Manoj Bhasin, PhD, MS
    Associate Professor, Department of Pediatrics
    Emory University School of Medicine
    Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta
    Characterization of Wnt/b-catenin pathway in modulating the anti-tumor immune response in advanced prostate cancer
  • Daqing Wu, PhD
    Professor, Center for Cancer Research and Biological Sciences, Clark Atlanta University
    A novel inhibitor of bone metastatic castration-resistant prostate cancer: efficacy and toxicology
  • Eric Miller, PhD
    Scientist, Department of Chemistry
    Emory College of Arts and Sciences
    Looking Backward to Move Forward - Cost-Effective Drug Combinations for Hormone-Refractory Prostate Cancer
  • Carlos Moreno, PhD
    Associate Professor, Department of Pathology and Laboratory Medicine
    Emory University School of Medicine
    Validation of Protein Biomarkers for Prostate Cancer Prognosis
  • Valeria Milam, PhD
    Associate Professor, School of Materials Science and Engineering
    Georgia Institute of Technology
    Implementing an efficient platform to identify superior ligands for sphingolipid targets

For more info, contact:

Cascade Link  TOP